UBS Group AG - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 39 filers reported holding VIVOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,777
-76.4%
9,257
-50.8%
0.00%
Q4 2022$7,525
+25.4%
18,812
+94.7%
0.00%
Q3 2022$6,000
+100.0%
9,663
+336.6%
0.00%
Q2 2022$3,000
-92.1%
2,213
-87.0%
0.00%
Q4 2021$38,000
+216.7%
17,083
+490.1%
0.00%
Q3 2021$12,0000.0%2,895
+23.7%
0.00%
Q2 2021$12,000
-14.3%
2,340
+10.5%
0.00%
Q1 2021$14,0002,1180.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Strategic Wealth Investment Group, LLC 3,219,705$1,098,2410.20%
BARD ASSOCIATES INC 201,704$68,8020.03%
PERKINS CAPITAL MANAGEMENT INC 22,500$80.01%
GODSEY & GIBB, INC 92,999$31,7220.00%
Virtu Financial LLC 46,013$160.00%
Wealth Alliance Advisory Group, LLC 17,498$5,9690.00%
Apexium Financial, LP 40,667$13,8720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,308$4460.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$68,8820.00%
View complete list of VIVOS THERAPEUTICS INC shareholders